Contact us: +91 9550333722 040 - 40102781
Structured search
India
Choose your country
Different countries will display different contents
Try our best to find the right business for you.
My chemicalbook

Welcome back!

HomecompanyPyrithiobac-sodium
Pyrithiobac-sodium
Pyrithiobac-sodium

Pyrithiobac-sodium

Price USD54860.00
Packge 1T
  • Min. Order:1T
  • Supply Ability:1-20mt
  • Time:2022-03-18

Product Details

  • Product NamePyrithiobac-sodium
  • CAS No.123343-16-8
  • EINECS No.602-931-3
  • MFC13H10ClN2NaO4S
  • MW348.74
  • AppearanceSolidYellow to Dark Yellow
  • storage temp. Keep in dark place,Inert atmosphere,2-8°C
  • Melting point 233-234°C
  • Water Solubility 705 g/L (pH7)

Melting point  233-234°C 

Fp  234°C 

storage temp.  0-6°C 

Water Solubility  705 g/L (pH7) 


Company Profile Introduction

Baoji Guokang Bio-Technology Co., Ltd. has a subsidiary, Baoji Guokang Health Chemical Technology Co., Ltd.It is located in Baoji High-tech Zone,with epitomizing international, cooperative and honest. We are a young company full of action and energy, our profession improves us rapid progress, which satisfy our clients both in home and abroad. We are specialized in API's intermediates, fine chemicals and plant extracts.We toughly insist on that quality is always the most important item not only for us, but also for our clients. It is believed that we could be considered as the most powerful man in the area of ​​chemicals with combined strength in R&D and Marketing. We are a "customer first" company and believe that our success depends on double-wins.our customers are from more than 160 countries worldwide ,we work closely with every customer to support high quality business service. Our target purpose is "provide favorable value,convenient and flexible solutions for you."we promise: reasonable prices, short supplying period and satisfactory after-sales service. Buyers are welcome to contact us !

  • Since:2008-05-08
  • Address: No.10,the 4th road of High-tech zone, Baoji City, Shaan’xi province, Mainland China
INQUIRY